Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head and Neck Carcinoma of Unknown Primary”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableStudy completedNCT03281499
What this trial is testing

Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 22
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Large-scale testing (Phase 3)Active Not RecruitingNCT00588770
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neck Squamous Cell Carcinoma of Unknown PrimaryRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+32 more
National Cancer Institute (NCI) 403
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Looking for participantsNCT05576974
What this trial is testing

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Who this might be right for
Head and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma
University of Texas Southwestern Medical Center 120
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableStudy completedNCT02047292
What this trial is testing

Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters

Who this might be right for
Hip Osteoarthritis
Istituto Ortopedico Rizzoli 30
Early research (Phase 1)Looking for participantsNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Early research (Phase 1)Not Yet RecruitingNCT07217028
What this trial is testing

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

Who this might be right for
SCC - Squamous Cell CarcinomaRadiotracerHead and Neck Squamous Cell Carcinoma+1 more
Vanderbilt-Ingram Cancer Center 60
Not applicableStudy completedNCT01984359
What this trial is testing

HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer

Who this might be right for
Subjects With p16 Positive/HPV Positive Squamous Cell Carcinomas of the Oropharynx
Abramson Cancer Center at Penn Medicine 80
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT05841966
What this trial is testing

Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary SiteUnknown Primary CancerUnknown Primary, Squamous Cell Carcinoma
Rigshospitalet, Denmark 30
Large-scale testing (Phase 3)Study completedNCT04189107
What this trial is testing

Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS

Who this might be right for
AnalgesiaSurgeryCancer of Head and Neck+4 more
Rigshospitalet, Denmark 18
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableLooking for participantsNCT07283939
What this trial is testing

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Who this might be right for
Ampulla of Vater CarcinomaAppendix CarcinomaCarcinoma of Unknown Primary With Gastrointestinal Profile+7 more
Alliance for Clinical Trials in Oncology 420
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Looking for participantsNCT05544136
What this trial is testing

Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck CarcinomaHead and Neck Neoplasms+1 more
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Testing effectiveness (Phase 2)Study completedNCT00003582
What this trial is testing

Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
University of Miami 36
Load More Results